Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Oncology Nurse Solves Dangerous IV Safety Problem


Tracy Lannan has recently conceived of the Spike-Guard, a unique protective device for intravenous (IV) units commonly found in hospitals, clinics and increasingly in remote/home use as well. As a longtime oncology nurse, Ms. Lannan is well aware of the day-to-day responsibilities and dangers faced by cancer patients and their caretakers. For many years, she has noticed that, by and large, the medical equipment industry has been neglecting the less-than-secure connection points between intravenous medication tubing and the bag or bottle containing medication/blood product.

The top of the IV drip structure has what’s called a “spike end” that is then linked up to an IV bag or bottle. It is that point of connection, as well as the one further down extending to the drip chamber, that have been problematic in Ms. Lannan’s experience. While other safety issues pertaining to IV therapy have been addressed to one degree or another, Ms. Lannan noticed that those particular points of connection remain as tenuous and unreliable as ever. As such, they continue to generate unpleasant, unsanitary and, considering that some of the treatment fluids in question cost over $20,000 per bag, costly surprises for her and millions of other healthcare workers and patients throughout the country.

Indeed, from messy spills of costly chemotherapy/immunotherapy/biotherapy fluids to safety-related complications that make remote IV therapy less viable and comfortable, Mrs. Lannan has witnessed the consequences of this problem firsthand. Unfortunately, it is not uncommon for cancer patients and others who undergo IV therapy to feel frail and lightheaded. When such incidents occur as they are walking with an IV structure beside them, they may grab the tube for support and inadvertently disconnect it from the IV bag or bottle, the contents of which may proceed to spill, as Lannan’s patent application describes the hazard, “onto the patient, the furniture, the floor, the IV pump, and/or soaking the patient’s clothing.”

As suggested by its name, Lannan’s patented Spike-Guard invention helps guard against such accidents. Consisting of an attachable clamp, the device is able to secure the spike by clamping it to the neck of a medication bottle or the stem of a medication bag. The Spike-Guard stabilizes the IV structure in a manner that can withstand the pressure of, for example, a patient grabbing on to a spike for support and does so for both connection points. Furthermore, as both the top and bottom clamps are removable, the Spike Guard is fully portable, versatile and suitable for use on multiple IV structures, if needed. As well, its application is simple enough for almost all patients to complete themselves, such as for cancer patients undergoing remote IV therapy of some sort.

Presently, Mrs. Lannan is communicating with various industry and regulatory stakeholders about the safety benefits of her breakthrough innovation. If you or your organization would like to reach out to her, you may do so through her new website, Spike-Guard.com (http://www.spike-guard.com). As well, through that site, you can gain access to additional Spike-Guard materials – including a brief demonstration video.

Share article on social media or email:

Highmark and axialHealthcare expand partnership with launch of member support program for substance use disorder


“Our Highmark members can now be guided by individuals with lived experience in the recovery space, have a simplified care navigation experience, and access resources to remove non-clinical barriers to care.” -Dr. Caesar DeLeo, VP and executive medical director of strategic initiatives, Highmark

axialHealthcare today announced a new recovery program with Highmark Inc. to offer care navigation and peer support services for members seeking treatment for substance use in Pennsylvania. This is a new addition to Highmark’s efforts to address substance use disorders and the opioid epidemic in the setting of the COVID-19 pandemic.

“This has been an extremely difficult year for individuals and families at all stages of recovery,” said Dr. Caesar DeLeo, vice president and executive medical director of strategic initiatives for Highmark. “COVID-19 has increased social isolation, stress and economic problems, while presenting additional hurdles in staying connected to or accessing treatment. Telemedicine expansion has been a great innovation and now we are adding to that peer support counselors through an expanded partnership with axialHealthcare. Our members can now be guided by individuals with lived experience in the recovery space, have a simplified care navigation experience, and access resources to remove non-clinical barriers to care.”

The recovery program deploys personalized services, using Pennsylvania-based clinicians and peer support from individuals in recovery to help members find and stay in treatment. Providing each member in need with a dedicated team, the program works with treatment providers to help coordinate care during critical transitions, connects members to social resources, and ultimately provides the dedicated, long-term support essential to sustained recovery.

“axialHealthcare is excited to expand our partnership with Highmark to help members and their families navigate a highly complex addiction treatment system,” said Dr. Dirk Wales, chief medical officer at axialHealthcare. “Our goal is to ensure members not only receive quality, coordinated care, but are also connected with any additional resources needed to stay in treatment and achieve recovery. We look forward to partnering with the treatment and recovery community to support safe, effective care for those most in need.”

The recovery program is an expansion of a multiyear partnership focused on ensuring evidence-based care for members in Pennsylvania and West Virginia. Since 2018, Highmark and axialHealthcare have tackled patient safety concerns related to substance use, spanning from decreased opioid overprescribing and polydrug use to increased naloxone prescribing and screening for SUD. These efforts have helped mitigate safety concerns, including decreasing the number of patients receiving opioids from multiple providers by 15.0%, reducing risky co-prescribing of benzodiazepines and opioids by 15.1% and increasing naloxone prescribing by 100% in two years.

Highmark strives to combat opioid addiction with a comprehensive approach that focuses on primary prevention, safe prescribing, high-quality treatment, community supports and combating stigma. Through these efforts, Highmark has reduced by 22.7% the number of commercial risk, Medicare Advantage and Affordable Care Act members in Pennsylvania who are prescribed opioids, while reducing opioid-related overdoses to a rate that is approximately half of the national average. Highmark has also provided more than $3 million to community organizations and programs fighting the opioid epidemic in its core markets of Pennsylvania, West Virginia and Delaware.

The recovery program is launching this month alongside select treatment providers in Pennsylvania. The program applies to Highmark’s commercial risk, Medicare Advantage and Affordable Care Act members who are being discharged from select inpatient treatment facilities in the commonwealth. For more information, contact axialHealthcare at accessrecoveryPA@axialHealthcare.com.

About axialHealthcare

axialHealthcare connects patients, providers, and health plans with an end-to-end platform that covers the entire substance use spectrum. Leveraging services grounded in analytics, our risk to recovery platform identifies patients at risk, prevents escalation in their condition, and supports appropriate treatment enrollment and adherence. This high-tech, high-touch approach delivers measurable clinical and financial outcomes by effectively managing cost of care while supporting sustained recovery for patients with substance use disorder.

About Highmark Inc.

One of America’s leading health insurance organizations and an independent licensee of the Blue Cross Blue Shield Association, Highmark Inc. (the Health Plan) and its affiliated health plans (collectively, the Health Plans) work passionately to deliver high-quality, accessible, understandable, and affordable experiences, outcomes, and solutions to customers. As the fourth-largest overall Blue Cross Blue Shield-affiliated organization, Highmark Inc. and its Blue-branded affiliates proudly cover the insurance needs of more than 5.6 million members in Pennsylvania, Delaware, and West Virginia. Its diversified businesses serve group customer and individual needs across the United States through dental insurance and other related businesses. For more information, visit http://www.highmark.com.

Share article on social media or email:

GuideWell Connect Successfully Completes 2020 SOC® 2 Type 2 Examination with 360 Advanced


News Image

“We place great value on serving our customers;” says Dr. LuAna Boykins, COO at GuideWell Connect. An essential part of that service is our continual focus on maintaining high levels of security, privacy, confidentiality and availability for our clients’ data.”

GuideWell Connect, a provider of health insurance business sales systems, today announced the successful completion of their 2020 System and Organizational Controls (SOC) 2® Type 2 examination. With long-standing experience in the health insurance industry, the company has completed annual SOC examinations for five consecutive years, reflecting a long-standing commitment to secure internal controls.

GuideWell Connect chooses to invest in their SOC 2 program because they take the security and privacy of their clients and customer data seriously. Continuous auditing and validation of their processes and procedures through SOC 2, supports the needs of their current and potential clients expectation of data security and protections.

GuideWell Connect was audited against the AICPA Trust Services Criteria for Security, Availability, Confidentiality and Privacy. The SOC 2 Type 2 examination provided assurance regarding the effectiveness of the company’s controls over a period of time.

The effort was completed by the professional and independent third-party audit firm, 360 Advanced, Inc.

“We place great value on serving our customers;” says Dr. LuAna Boykins, COO at GuideWell Connect. An essential part of that service is our continual focus on maintaining high levels of security, privacy, confidentiality and availability for our clients’ data. Securing our SOC 2 Type 2 Certification once again demonstrates that commitment to our clients.”

About GuideWell Connect

A wholly owned subsidiary of the GuideWell Mutual Holding Corporation (“GuideWell”), GuideWell Connect is a leader in integrated consumer engagement solutions that helps health plans attract, engage and retain members. GuideWell Connect provides technology-enabled services across the member lifecycle to advance health plans’ financial performance, grow membership, and drive better health outcomes for members. GuideWell Connect is the consumer engagement business of GuideWell Mutual Holding Corporation. Learn more at http://www.guidewellconnect.com.

For GuideWell Connect inquiries, please contact:

Meg Cook

Sr. Director of Marketing

megan_cook@onlifehealth.com

About 360 Advanced

360 Advanced is “Making Better Businesses” through their Cybersecurity and Compliance offerings. Services provided include SOC 1, SOC 2, SOC 3, SOC for Cybersecurity, SOC for Supply Chain, CSA STAR, HIPAA/HITECH, ISO 27001 and 27701, PCI-DSS, HITRUST CSF, Microsoft SSPA Attestation, Penetration Testing, GDPR, CCPA, PIPEDA, GLBA, FFIEC, MARS-E and more. In certain states, 360 Advanced may operate under the name of Hiestand, Brand, Loughran, P.A. to meet State Board requirements for CPA firms. To learn more about 360 Advanced, visit http://www.360advanced.com.

For more information on compliance solutions, contact Jim Brennan at jbrennan@360advanced.com.

Media Contact:

Eric Seward

eseward@360advanced.com

Share article on social media or email:

The Journey Begins for the 36th Annual iaedp™ Symposium; Registration Now Open


“Each year, our mission at iaedp™ is to bring together the leading authorities in research and treatment of eating disorders and co-occurring addictions. Even with the challenges of Covid, this mission continues,” said Bonnie Harken, Managing Director at the iaedp™ Foundation.

The International Association of Eating Disorders Professionals Foundation (iaedp™) has announced the opening of early registration for the upcoming 2021 iaedp™ Symposium, available to February 12, 2021. Given the coronavirus environment, the 2021 iaedp™ Symposium will be provided to participants in a virtual format. Early registration offers $50 off full price to February 12, 2021.

The theme, “As the World Turns: Unforeseen Challenges and Dynamic Solutions,” sets the tone as a central focus for the more than 60 presentations and workshops, world-renowned keynote speakers, special networking events from all parts of the globe – all available to registered participants 24/7 from March 18, 2021 to September 1, 2021.

Established in 1985, iaedp™ (http://www.iaedp.com) provides educational programs in multiple languages and training standards for eating disorder specialists and other medical professionals caring for those suffering from the full spectrum of disordered eating.

“Each year, our mission at iaedp™ is to bring together the leading authorities in research and treatment of eating disorders and co-occurring addictions. Even with the challenges of Covid, this mission continues,” said Bonnie Harken, Managing Director at the iaedp™ Foundation. “We identify those truly outstanding in our field – those professionals who have accomplished innovative treatment work and research — to help all of us in the treatment of eating disorders do the best job possible to fight for those who suffer from addictive diseases.”    

The 2021 iaedp™ Symposium in a virtual format offers training sessions and instructive presentations with experts from various disciplines in the field of eating disorders. Over the next several months, speakers, activities, workshops and other presentations as well as special offerings for participants will be announced for the upcoming 2021 iaedp™ Symposium.

About the iaedp™ Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. MemberSHARE.iaedp.com is an iaedp™ business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and international chapter activity and events; for more information, visit MemberSHARE.

The Presidents Council provides iaedp™ support and includes: Center for Change; Center for Discovery; Eating Recovery Center; Willow Place; Laureate Eating Disorders Program; The Meadows Ranch; Rogers Behavioral Health; Rosewood Centers for Eating Disorders; Selah House; The Renfrew Center; Timberline Knolls; Veritas Collaborative; Alsana Eating Disorder Treatment & Recovery Centers; Walden Behavioral Care, KIPU and SunCloud Health.

Share article on social media or email:

Emanate Health Queen of the Valley Hospital in West Covina Earns Primary Plus Stroke Center Designation


Emanate Health

Bi-plane technology is used to perform thrombectomy procedures to remove blood clots at Emanate Health.

“Time is brain and by offering this high level of care at Queen of the Valley Hospital allows stroke victims to receive emergency care far sooner instead of ambulance transport to a distant facility elsewhere,” said Emanate Health CEO Robert H. Curry.

Emanate Health Queen of the Valley Hospital in West Covina has received certification from DNV-GL Healthcare as a Primary Plus Stroke Center (PSC+), reflecting a high level of competence for treatment of complex and serious stroke events. DNV-GL is one of the two most prestigious stroke care certification entities in the country.

The PSC+ Program Certification includes all the requirements of the Primary Stroke Program (PSC) with the addition of thrombectomy capabilities, medical staff and metric requirements that are in a comprehensive stroke program. A thrombectomy is an interventional procedure for the removal of a blood clot from an artery or vessel.

“This designation demonstrates Emanate Health’s commitment to provide stroke victims in the San Gabriel Valley with the best possible care in their immediate community,” said Emanate Health CEO Robert H. Curry. “Time is brain and by offering this high level of care at Queen of the Valley Hospital allows stroke victims to receive emergency care far sooner instead of ambulance transport to a distant facility elsewhere.”

According to the American Stroke Association, about 795,000 Americans each year suffer a new or recurrent stroke. That means, on average, a stroke occurs every 40 seconds. Stroke kills more than 137,000 people a year and is one of the leading causes of death. On average, every four minutes someone dies of stroke and is a leading cause of serious, long-term adult disability. Because stroke affects blood flow to the brain, response time and immediate treatment is crucial to limiting the extent of long-term damage.

DNV-GL’s new stroke care certification is for organizations that meet the requirements of the primary stroke program and are fully thrombectomy capable but cannot quite meet the Comprehensive Stroke Center requirements due to reasons such as volume requirements or capability to provide full services, as required.

Queen of Valley Hospital received a rigorous on-site review in October 2020 to determine if it complied with stroke-care standards and requirements established by DNV-GL Healthcare. This certification from DNV-GL validates the hospital stroke program at the highest level of quality and capability to deliver optimal patient outcomes and safety.

“We’re grateful for this certification because it’s a critical step on our road for Emanate Health to become a Comprehensive Stroke Center and we’re confident that we’ll achieve this designation soon,” Curry said.

Queen of the Valley Hospital is working to become a Comprehensive Stroke Center by demonstrating that it has the highest level of infrastructure, imaging capabilities, specially trained neurology specialist and staff ready at all times to treat complex strokes and provide specialized treatment options including medications and neuro-intervention procedures available 24/7.

About Emanate Health

Emanate Health, http://www.emanatehealth.org, is the largest nonprofit health care provider serving the one million residents of the San Gabriel Valley in California. The system provides specialized care in Behavioral Health, Cancer, Cardiovascular, Emergency, Neuroscience and Stroke, Orthopedics, Sports Medicine, and Women’s Health. Its family of hospitals and hospice include Emanate Health Inter-Community in Covina, and Emanate Health Queen of the Valley in West Covina, Emanate Health Foothill Presbyterian in Glendora, Emanate Health Hospice and Emanate Health Home Care in West Covina, as well as other clinics throughout the region. Year after year the health care system has been voted “Best Hospital” and “Best Place to Work” and providers are consistently among the “Top Doctors” in Los Angeles County and hospitals are graded A for Patient Safety by The Leapfrog Group. Visit emanatehealth.org, our Newsroom and connect with us on LinkedIn │Twitter│ Instagram │ Facebook.

Share article on social media or email:



Zoom to the North Pole and Visit Santa Claus for a Great Cause


“Many of the patients we serve are children that fall in the COVID high risk category due to conditions caused by brain tumors or the treatment of them,” said Amy Wood, RAWF executive director. “We wanted to keep up the holiday spirit for those kids that have been in quarantine for so long.”

With increasing COVID-19 restrictions around the holidays, the Raymond A. Wood Foundation, a nonprofit organization providing quality of life support to child and adult brain tumor survivors, joins forces with Santa Claus to provide one-on-one Zoom sessions. Now children have an opportunity to let Santa know what they are hoping to find under their trees this year…virtually!

Parents are invited to visit ZoomtotheNorthPole.org,and book a 5 minute session with Mr. Claus for a small donation to the foundation. Santa will join via Zoom meeting straight from the North Pole, ready to hear wish lists from around the country. The sessions take place on Saturdays and Sundays, from 11am – 2pm EST through December 19th.

“Many of the patients we serve are children that fall in the COVID high risk category due to conditions caused by brain tumors or the treatment of them,” said Amy Wood, RAWF executive director. “We wanted to keep up the holiday spirit for those kids that have been in quarantine for so long and figured it would be a great opportunity for all children to get some time with Santa, despite the pandemic.”

Santa kicked off his virtual visits last weekend with meetings with boys and girls hoping for new Lego sets, virtual reality games and drones but Santa also fielded quite a few questions about how reindeer fly and if he could get caught on camera on Christmas Eve.

One mom wrote, “This is HANDS DOWN the BEST Santa visit we’ve ever had – thank you so much! Santa was perfect and so kind! Loved all his answers to the kids’ questions.”

Parents can book visits with Santa by going to ZoomtotheNorthPole.org. All proceeds benefit the Raymond A. Wood Foundation, a Maryland-based nonprofit organization that helps brain tumor survivors nationally and globally, who face challenging lifelong chronic conditions from tumor treatment while providing caregiver support. For more information, visit rawoodfoundation.org

Share article on social media or email:

Santa Claus Has New Test For Fake Germicidal UV Light Wand Stocking Stuffers With QuantaDose UVC Light Wand Test Card


Ho Ho Ho Viruses Must Go! Santa Test UVC Light With QuantaDose UVC test Card

Santa testing a UVC light wand with the QuantaDose UVC test card!

“..and how often is a UV light wand tested to make sure it isn’t a fake UV-C light? Consumers should always confirm the UV light manufacturers UV-C wavelength and UV-C power claims”, said Coates, the American inventor behind the reusable QuantaDose UVC light test card.

Quanta X Technology, the parent company of QuantaDose, CEO Katie Webb suggests, “Anyone in Santa’s shoes gifting a UVC device to a friend or family member needs to make sure the UV-C device is real, and they also need to understand the potential dangers when using a UVC device for disinfecting objects and surfaces. Real UV-C lights aren’t toys made by Santa’s elves as UVC light can damage your eyes in seconds and burn your skin.”

“In fact, UV-C light is a well-known carcinogen, and some UV light devices will produce ozone as a result of 184nm light from the mercury spectrum line escaping a quartz glass tube. Ozone producing UV lights require even more safety precautions that are worth checking twice — to see if your UV products being gifted this holiday season are naughty or nice,” said Webb.

According to QuantaDose, “confusion has found the most fertile of breeding grounds as consumers attempt to weigh virus prevention advice coming at them from all directions during the COVID-19 pandemic.“

The 1961 novel Catch 22, by author Joseph Heller, may have said it best: “In confusion there is profit.” 2020 has been like no year in modern history as shoppers put their blind faith into the claims of untested personal protection devices sold online that can make the difference between life or death in an outbreak.

In this confusion, profits have soared for online retailers like Amazon that offer an almost unlimited selection of sanitizing products. Many devices sold by third-party sellers on these marketplaces make unverified claims regarding UV disinfecting power wavelengths used in these devices for virus protection. As it turns out, there is no shortage of fake UV disinfection products on the market.

The QuantaDose UVC light test card aims to reduce consumer confusion when choosing a real UV-C light solution capable of meeting their cleaning needs. World-class phone support is even available from a toll-free number on the back of the QuantaDose UV-C test card (1-800-713-9004) to help consumers spot fake UVC LEDs and Lamps.

“UV light is a valuable tool providing the UV wavelength, UV power, and UV duration are suitable for the application,” notes John Coates, CTO and senior research scientist at Quanta X Technology.

“The reality is that with something like a handheld UVC light wand, it’s the distance, it’s the intensity of the UV light, it’s the wavelength of UV-C light, and the duration of UV irradiance. That’s not all, said Coates,” It’s the surface that you’re waving this UV wand over. Is it marble? Is it glass? Is it wood? Is it your mail or a face mask? This all matters… and how often is a UV light wand tested to make sure it isn’t a fake UV-C light? Consumers should always confirm the UV light manufacturers UV-C wavelength and UV-C power claims”, said Coates, the American inventor behind the reusable QuantaDose UVC light test card.

When you purchase a QuantaDose UVC test card, you have access to highly trained professionals in the USA at 1 800 713-9004 that can help you through whatever UV light testing or UVC setup questions you have. QuantaDose doesn’t have a vested interest in the UV lights you use, only that you have real UV lights and enough power to do the job in the time you require to stay safe.

There are hundreds of different style UVC lights on the market. QuantaDose will walk you through the process of validating any of them with a live real person. Many of the support calls are answered by the QuantaDose card’s inventor, so no questions are too big or too small.

Webb emphasizes, “The only bad question about testing UVC lighting is the one that isn’t asked to ensure consumers are not using fake UVC lighting to protect themselves and loved ones.”

“QuantaDose is here to help take any confusion out of the equation when it comes to verifying that UVC lights are real and effective virus precautions. We’re here to take the mystery and confusion out of the UVC disinfection process,” said Coates.

QuantaDose is available on Amazon with same day delivery in many areas in the USA. Visit the QuantaDose Amazon Store

About QuantaDose

Designed and Engineered in the USA, QuantaDose uses molecular fluorescence and the quantum confinement effect for photochromatic WPV (Word Power Visibility) technology to provide reliable UVC intensity readings in 15 seconds with instant notification of optimal UVC germicidal wavelengths. The QuantaDose UVC intensity test card relies on calibrated word legibility starting > 300 µW/cm² when the word ” ULTRAVIOLET” first becomes legible during exposure to optimal UVC germicidal wavelengths.

QuantaDose UVC test cards are a basic, reliable, low cost, simple, in-house, and right out of your pocket method of monitoring UVC intensity along with verifying that the optimal UVC light wavelengths are being used in your disinfection process without spending hundreds of dollars on fragile UV and UVC light meters.

When exposed to optimal UVC germicidal wavelengths, the QuantaDose UVC test card undergoes an instant color change to glow green, where fluorescence is directly related to the energy value of the UV wavelength received. Fluorescence stops instantly when excited electrons release all photons within nanoseconds after exposure.

QuantaDose has created this specially formulated ink chemistry sensitive to only optimal UV-C, which will not fluoresce to visible light or UVA and UVB. The QuantaDose test confirms that only wavelengths between 222nn-280nm are shown in glowing green letters UV-C. QuantaDose gives you instant verification of UV-C wavelengths to avoid an increasing number of fake UVC light products on the market today.

QuantaDose UVC test cards can be purchased online from the company’s website at https://www.quantadose.com.

QuantaDose™ 1st Edition Reusable 300 µW/cm² UVC Intensity Test Card With UVC Wavelength Indicator Test

1st Edition Available on Amazon

QuantaDose™ 2nd Edition Reusable UVC Test Cards 300 µW/cm² Minimum Intensity w/UVC Wavelength Indicator

2nd Edition Available on Amazon

Share article on social media or email:

Roswell Park Leukemia Chief Shares Promising Findings on New Treatment Options at ASH 2020


It’s encouraging to see signals of efficacy and evidence of good tolerability in these emerging treatment options, especially for subgroups of patients with AML whose cancers have been especially resistant to other therapies.

Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive Cancer Center, is leading multiple research efforts focused on different treatment approaches for acute myeloid leukemia (AML) patients. Today, during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, which is being held virtually, she is presenting data on two ongoing studies incorporating new treatment options.

KOMET-001 (NCT04067336) is an ongoing phase I/IIA open-label study evaluating KO-539, a once-daily oral drug, in adult AML patients at Roswell Park and select other sites in the U.S. and Europe. KO-539 is a novel experimental inhibitor of the menin-KMT2A complex, which is dysregulated in acute leukemias characterized by rearrangements in the MLL gene and mutations in the NPM1 gene.

The phase I dose-escalation aims to assess safety and tolerability, characterize the pharmacokinetics, and determine a recommended phase II dose. Researchers will examine anti-leukemic activity, pharmacokinetics, safety and tolerability in patients with select genetic subtypes of AML during the phase IIA dose expansion.

“Preliminary results demonstrate that the drug appears to be safe and well-tolerated in adult patients with relapsed/refractory AML failing 3-7 prior lines of therapy,” says Dr. Wang. “None of 12 patients treated to date have discontinued therapy due to toxicity. Moreover, six of eight evaluable patients to date have shown some evidence of anti-leukemic activity, with two individuals achieving complete remissions on therapy. This promising trial continues to enroll.”

Dr. Wang will also present early findings from the randomized, multicenter, open-label phase III LACEWING study exploring the efficacy of gilteritinib, a FLT3 inhibitor, combined with low-dose chemotherapy compared to low-dose chemotherapy alone. Eligible patients include those with newly diagnosed FLT3 mutant AML who are considered unfit for intensive chemotherapy.

The primary objective of this study was overall survival. Secondary endpoints included event-free survival, best response, remission rates and duration, transfusion conversion and maintenance rates, leukemia-free survival, patient-reported fatigue, and safety/tolerability.

Patients in an initial safety cohort received gilteritinib (80-120 mg daily) plus the low-dose chemotherapy azacitidine. Mature data presented today show that 10 of 15 patients (67%) achieved a complete response or complete response, with incomplete count recovery on therapy with a median overall survival of 10.4 months. The adverse events observed by researchers were hematologic and no new safety signals have been associated with gilteritinib (120 mg daily) when combined with azacitidine.

Enrollment in the randomized portion of the LACEWING trial is ongoing, with 136 of 250 anticipated patients accrued to date. Patients in this group will be randomized 2:1 to receive oral gilteritinib in combination with azacitidine. Based on data from the safety cohort, patients will receive a gilteritinib dose of 120 mg daily alongside low-dose chemotherapy.

“It’s encouraging to see signals of efficacy and evidence of good tolerability in these emerging treatment options, especially for subgroups of patients with AML whose cancers have been especially resistant to other therapies,” notes Dr. Wang.

ASH 2020 Presentation Details:

Preliminary Data on a Phase 1/2A First in Human Study of the Menin-KMT2A (MLL) Inhibitor KO-539 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Abstract 115

Presenting author: Eunice Wang, MD, Roswell Park Comprehensive Cancer Center

Time/date: Saturday, Dec. 5, 10:30 a.m. PST

Session: 616, Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel promising therapies for relapsed/refractory AML

Phase 3, Multicenter, Open-Label Study of Gilteritinib, Gilteritinib Plus Azacitidine, or Azacitidine Alone in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Induction Chemotherapy

Abstract 27

Presenting author: Eunice Wang, MD, Roswell Park Comprehensive Cancer Center

Time/date: Saturday, December 5, 8:15 a.m. PST

Session: 616, Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Novel combination therapies in treatment of newly diagnosed AML

For an online version of this release, please visit: https://www.roswellpark.org/newsroom/202012-roswell-park-leukemia-chief-shares-promising-findings-new-treatment-options-ash

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

Share article on social media or email:

Wave Plastic Surgery Offers December Specials on Cosmetic Procedures


This December might be an unexpected time to get a cosmetic procedure. But with everyone encouraged to stay inside this winter, a lot of people are jumping at the opportunity to enhance their appearance while they recover comfortably at home. Working remotely makes recuperation even easier as plastic surgery patrons opt to switch off their Zoom cameras and continue working from the privacy of their homes.

Winter has historically been considered the best time of year to get Plastic Surgery because bulky clothes, turtlenecks, and scarves allow patients to conceal swelling after their procedure. The cooler weather also helps keep inflammation in check. Shorter days make staying out of direct sunlight easier, which is typically recommended after surgical procedures to minimize the pigmentation of scars.

To make this opportunity even more alluring, renowned plastic surgery practices like Wave Plastic Surgery are offering a variety of special offers on both surgical and non-surgical cosmetic procedures. Throughout the month of December, Wave is offering deals on popular non-surgical procedures like Juveau. Neuromodulators like Juveau use a purified form of botulinum toxin to relax the facial muscles and get rid of frown lines. This wrinkle-reducing treatment is the perfect way to cap off a rough year that gave a lot of us some extra age lines.

Others may want to take full advantage of working remotely and having a clear social calendar by getting a facelift. There are a number of different types of facelifts offered at most Plastic Surgery practices. Wave is offering 30% off of their Curelift procedure during the month of December. The Curelift is a Wave-exclusive mini face and neck lift that serves as an alternative to a traditional facelift. The Curelift offers natural-looking results with dramatically reduced recovery time and virtually no scarring. This winter, the ubiquity of facial masks can keep any post-surgery puffiness private.

December 2020 may seem like a hard end to a harder year, but many people are choosing to give themselves a gift this holiday season by taking years off of their appearance. This Christmas people across the country are pampering themselves with an age-defying cosmetic procedure to give them the confidence to take on the new year.

Have any questions? Schedule a Virtual Consultation at WavePlasticSurgery.com or Call 888-674-3001Today!

Share article on social media or email:

Dr. Paul Vitenas Named One of Castle Connelly’s Top Doctors Five Years in a Row


Dr. Paul Vitenas Named One of Castle Connelly’s Top Doctors Five Years in a Row

Dr. Paul Vitenas Named One of Castle Connelly’s Top Doctors Five Years in a Row

Showcasing his dedication to the craft of plastic surgery and patient care, board-certified Houston plastic surgeon Paul Vitenas, Jr., M.D., F.A.C.S. has been named a Castle Connelly Top Doctor in 2020, for the fifth consecutive year. Dr. Vitenas continues to impress colleagues and patients, resulting in his inclusion on the Top Doctors list for five years in a row. Only about 60,000 doctors (of around 850,000) in the United States are selected for this honor each year, across all specialties.

The Top Doctors selection process is rigorous and is designed to recognize only the best of the best. Doctors are nominated by their peers before a physician-led committee reviews the nominations and selects the doctors who will make the list. Doctors who are ultimately included are experienced yet innovative and have made an ongoing commitment to providing quality care.

The Castle Connelly Top Doctors list is extremely prestigious because it is unbiased. Doctors cannot pay to be on the list and the selection process is free from conflicts of interest. The committee evaluates each nominee using a huge number of factors, from education and research history to professional reputation, disciplinary history and outcome data. Prospective patients can enjoy peace of mind when looking for a new physician through Castle Connelly because only the top doctors in each state make the list. It is a reliable source of information for anyone who needs medical care.

Dr. Vitenas prides himself on his approach to cosmetic medicine. At Vitenas Cosmetic Surgery, he has been offering patients customized procedures since 1990. Although Dr. Vitenas has decades of experience in private practice, he is committed to staying on the cutting edge of aesthetic medicine and introducing advanced technology to his practice whenever necessary.

Known as one of the top plastic surgeons in Texas and the country as a whole, Dr. Vitenas offers patients a range of effective procedures. He is known for his incredible breast surgery results, from breast augmentation to breast lifts and reductions. He offers a range of body contouring and rejuvenation procedures such as liposuction, mommy-makeover and vaginal rejuvenation. Dr. Vitenas is also an extremely skilled facial surgeon, performing facelifts, rhinoplasty, fat transfer, blepharoplasty and more.

Dr. Vitenas was trained at Tulane University and is board-certified by the American Board of Plastic Surgery. Over the years, he has earned a huge number of awards through his work at Vitenas Cosmetic Surgery. He also runs and oversees a state-of-the-art medical spa, Mirror Mirror Beauty Boutique, which is known for incredible non-surgical treatments like CoolSculpting. Dr. Vitenas works with top medical professionals to deliver unparalleled, customized care at both facilities.

Patients at Vitenas Cosmetic Surgery and Mirror Mirror Beauty Boutique know just how dedicated Dr. Vitenas is to their results and well-being. If you would like to learn more about any of the procedures Dr. Vitenas offers, visit the Vitenas Cosmetic Surgery website or call 281.484.0088 today.

Share article on social media or email: